找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: Cancer Immunotherapy Meets Oncology; In Honor of Christop Cedrik Michael Britten,Sebastian Kreiter,Hans-Geor Book 2014 Springer Internation

[復制鏈接]
查看: 31939|回復: 57
樓主
發(fā)表于 2025-3-21 19:41:57 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱Cancer Immunotherapy Meets Oncology
副標題In Honor of Christop
編輯Cedrik Michael Britten,Sebastian Kreiter,Hans-Geor
視頻videohttp://file.papertrans.cn/222/221139/221139.mp4
概述Provides a comprehensive update on the state of the art in cancer immunology.Describes the most promising therapeutic concepts, with coverage of combination therapies and personalized medicine.Discuss
圖書封面Titlebook: Cancer Immunotherapy Meets Oncology; In Honor of Christop Cedrik Michael Britten,Sebastian Kreiter,Hans-Geor Book 2014 Springer Internation
描述.This book provides a comprehensive update on the state of the art in cancer immunology, which has rapidly evolved from a field of clinical research into an established discipline of oncology. The key recent developments in immuno-oncology are all covered, from the ever-changing immunological and regulatory frameworks to the most promising therapeutic concepts. Themes include combination therapies and personalized medicine, as well as identification of biomarkers to guide the clinical development of new approaches and to pinpoint the optimal treatment for each patient. The book acknowledges the continuing dynamic nature of the field as reflected in the development of next-generation immunotherapies that are already in clinical testing..Cancer Immunotherapy Meets Oncology. is dedicated to the lifetime achievements of Christoph Huber, founder and chair of the Association for Cancer Immunotherapy (CIMT). It is also a tribute to those researchers and clinicians who are striving to develop novel diagnostics and tailored immunotherapies for the benefit of cancer patients..
出版日期Book 2014
關鍵詞Biomarkers; Cancer Immunotherapy; Immuno-Oncology; Novel Treatments
版次1
doihttps://doi.org/10.1007/978-3-319-05104-8
isbn_softcover978-3-319-38126-8
isbn_ebook978-3-319-05104-8
copyrightSpringer International Publishing Switzerland 2014
The information of publication is updating

書目名稱Cancer Immunotherapy Meets Oncology影響因子(影響力)




書目名稱Cancer Immunotherapy Meets Oncology影響因子(影響力)學科排名




書目名稱Cancer Immunotherapy Meets Oncology網(wǎng)絡公開度




書目名稱Cancer Immunotherapy Meets Oncology網(wǎng)絡公開度學科排名




書目名稱Cancer Immunotherapy Meets Oncology被引頻次




書目名稱Cancer Immunotherapy Meets Oncology被引頻次學科排名




書目名稱Cancer Immunotherapy Meets Oncology年度引用




書目名稱Cancer Immunotherapy Meets Oncology年度引用學科排名




書目名稱Cancer Immunotherapy Meets Oncology讀者反饋




書目名稱Cancer Immunotherapy Meets Oncology讀者反饋學科排名




單選投票, 共有 1 人參與投票
 

0票 0.00%

Perfect with Aesthetics

 

1票 100.00%

Better Implies Difficulty

 

0票 0.00%

Good and Satisfactory

 

0票 0.00%

Adverse Performance

 

0票 0.00%

Disdainful Garbage

您所在的用戶組沒有投票權(quán)限
沙發(fā)
發(fā)表于 2025-3-22 00:18:44 | 只看該作者
板凳
發(fā)表于 2025-3-22 03:18:22 | 只看該作者
地板
發(fā)表于 2025-3-22 07:21:42 | 只看該作者
5#
發(fā)表于 2025-3-22 11:16:08 | 只看該作者
6#
發(fā)表于 2025-3-22 15:25:28 | 只看該作者
Evolution of the Regulatory Landscape for Immunomodulatory Compounds and Personalized Therapeutic Ca safety profile on the other. Here, we briefly summarize the regulatory classification of immunotherapy approaches. The second part focuses on the evolving regulatory landscape for nonpersonalized and personalized cancer vaccines that have been in the focus of the CIMT regulatory research group during the last years.
7#
發(fā)表于 2025-3-22 17:13:20 | 只看該作者
8#
發(fā)表于 2025-3-22 21:35:17 | 只看該作者
The Express Drivers: Chimeric Antigen Receptor-Redirected T Cells Make It to the Clinic) conditions, engineered by viral vector- or nucleic acid-based gene transfer with the CAR, amplified to therapeutic numbers, and readministered to the patient. Successes in recent trials sustain the hope that specifically redirected patient T cells can control cancer in the long term.
9#
發(fā)表于 2025-3-23 03:37:23 | 只看該作者
Book 2014er Immunotherapy Meets Oncology. is dedicated to the lifetime achievements of Christoph Huber, founder and chair of the Association for Cancer Immunotherapy (CIMT). It is also a tribute to those researchers and clinicians who are striving to develop novel diagnostics and tailored immunotherapies for the benefit of cancer patients..
10#
發(fā)表于 2025-3-23 06:16:42 | 只看該作者
Book 2014nto an established discipline of oncology. The key recent developments in immuno-oncology are all covered, from the ever-changing immunological and regulatory frameworks to the most promising therapeutic concepts. Themes include combination therapies and personalized medicine, as well as identificat
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-20 11:30
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復 返回頂部 返回列表
赤壁市| 合江县| 赤壁市| 南雄市| 凭祥市| 鄯善县| 南皮县| 商河县| 柳江县| 蓬溪县| 洛扎县| 尼勒克县| 鄂温| 松桃| 瑞丽市| 通河县| 容城县| 台北市| 乌鲁木齐市| 渝中区| 墨竹工卡县| 漳浦县| 化隆| 富锦市| 嵊泗县| 辰溪县| 阿图什市| 夏津县| 瓦房店市| 枣阳市| 西昌市| 内丘县| 佛冈县| 昂仁县| 怀安县| 抚顺县| 龙海市| 鄂尔多斯市| 丹巴县| 青海省| 平安县|